Biotechnology · Healthcare
Chief Accounting Officer
2026-01-29–present
Chief Accounting Officer
Aligos Therapeutics, Inc. (ALGS)Equibles does not estimate personal net worth.
Get an email with a short summary when Aligos Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ALGS alertsNikhil Aneja is recorded as Chief Accounting Officer at Aligos Therapeutics, Inc. (ALGS) since January 29, 2026. Aligos Therapeutics, Inc. reported in an 8-K filed February 4, 2026 that Nikhil Aneja was appointed Principal Accounting Officer, effective January 29, 2026. Aligos Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aligos Therapeutics, Inc. includes Lawrence M. Blatt (CEO and Board Member), Lesley Ann Calhoun (CFO and COO), Lucinda Y. Quan (General Counsel) and 7 others.
“On January 29, 2026, the Board of Directors of Aligos Therapeutics, Inc. (the "Company") appointed Nikhil Aneja as the Company's Principal Accounting Officer, effective immediately.”
2026-01-29–present
Biotechnology · Healthcare
Chief Accounting Officer
2026-01-29–present